Answers are grounded in this paper and cite their sources.
Efficient transport of antioxidant therapeutics across brain-associated barriers remains a major challenge for neuroprotective strategies. Here, we report caffeic acid–functionalized gold nanoparticles (AuNPs–CA) engineered to enhance passive diffusion and provide intrinsic redox activity. Monodisperse ∼ 12 nm AuNPs were synthesized and covalently conjugated with caffeic acid, yielding stable nanoconjugated systems that retained the catechol–quinone redox interconversion essential for antioxidant function. Transport properties were evaluated using a non-cellular, electrospun PMMA–gelatin scaffold designed as a simplified passive-diffusion model that mimics selected structural features of the blood–brain barrier. AuNPs–CA exhibited controlled release of caffeic acid under enzymatic degradation and demonstrated significantly improved diffusion compared to free CA. SH-SY5Y neuronal-like cells showed high viability upon exposure to the nanoconjugated systems and also preserved their normal morphology. Antioxidant assays confirmed strong radical-scavenging activity, indicating that the conjugation strategy maintains the redox functionality of caffeic acid. These findings establish AuNPs–CA as a dual-function nanoplatform that couples enhanced passive diffusion through a simulated barrier with robust neuroprotective properties, supporting their potential utility in future therapeutic approaches targeting oxidative stress–related neurodegenerative conditions.
No takes yet. Share an insight, caveat, or question.
Nistor et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: